Researchers discover how to boost vaccine designed to prevent melanoma recurrence

(The Mount Sinai Hospital / Mount Sinai School of Medicine) A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system cells called dendritic cells, according to phase 2 clinical trial results published in Nature Cancer in November.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news